Hedelix (Extract Of Hedera Helix Folium (2.2 – 2.9 : 1), Extracting Agent: Ethanol 50% (V / V), Propylene Gly)

Hedelix is derived from ivy leaf extract, a botanical that has traditionally been employed in herbal practice for certain respiratory and mucosal conditions.

• Support of normal bronchial function in mild, occasional coughs.
• Adjunctive use for the relief of throat irritation associated with dry or smoky environments.
• Traditional herbal preparation for promoting the clearance of mucus from the upper airways.
• Complementary option in herbal protocols aimed at soothing occasional hoarseness.
• Used in some European phytotherapy guidelines as a non‑prescription botanical for occasional respiratory discomfort.

The safety profile of Hedelix reflects observations from clinical use of ivy leaf extracts; most reported reactions are mild and reversible.

Common

• Mild gastrointestinal discomfort such as nausea or abdominal cramping.
• Transient skin redness at the oral mucosa.
• Brief increase in salivation.
• Mild headache.
• Occasional dizziness.

Serious

• Allergic reactions ranging from urticaria to angioedema.
• Signs of hepatotoxicity, although rare, reported in isolated case reports.
• Severe bronchospasm in susceptible individuals.
• Persistent vomiting.

When considering Hedelix, several precautionary points should be reviewed to ensure safe use, especially in specific population groups and health conditions.

• Do not use if you have a known hypersensitivity to ivy leaf or any formulation excipients.
• Pregnant or breastfeeding individuals should consult a health professional before use.
• People with chronic liver disease should seek medical advice prior to taking the product.
• Concurrent use with other expectorants or cough suppressants should be discussed with a clinician.
• Children under the age of 12 should not use Hedelix unless directed by a qualified practitioner.

Ivy leaf extracts may influence the activity of certain medicines; awareness of potential interactions helps to avoid adverse effects.

Avoid

• Concurrent use with potent anticoagulants such as warfarin, as herbal constituents could theoretically affect clotting.
• Combination with other herbal expectorants or mucolytics without professional guidance.

Use with caution

• Co‑administration with bronchodilators or asthma medications; monitor for unexpected bronchial responses.
• Use together with hepatically metabolised drugs; consider liver function monitoring.
• Concurrent intake of other gastrointestinal irritants; observe for amplified GI discomfort.